Gene expression signatures of coronary heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 6, 2013, Pages 1418-1426

  Joehanes, Roby ^a,b,c   Ying, Saixia ^c   Huan, Tianxiao ^a,b   Johnson, Andrew D ^a,b   Raghavachari, Nalini ^b   Wang, Richard ^b   Liu, Poching ^b   Woodhouse, Kimberly A ^b   Sen, Shurjo K ^d   Tanriverdi, Kahraman ^e,g   Courchesne, Paul ^a,b   Freedman, Jane E ^e,f   O'Donnell, Christopher J ^a,b,g   Levy, Daniel ^a,b   Munson, Peter J ^c  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biomarkers; Coronary artery disease; Coronary heart disease; Gene expression; Myocardial infarction; Transcriptomics

Indexed keywords

GRANZYME B; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CARDIOVASCULAR RISK; CELL ACTIVITY; CELL SUBPOPULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROID CELL; ERYTHROPOIESIS; EXCISION REPAIR; EXON; EXTENDED FAMILY; FEMALE; FOAM CELL; GENE CLUSTER; GENE EXPRESSION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSCRIPTOMICS; UBIQUITINATION;

BIOMARKERS; CORONARY ARTERY DISEASE; CORONARY HEART DISEASE; GENE EXPRESSION; MYOCARDIAL INFARCTION; TRANSCRIPTOMICS;

AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CORONARY DISEASE; DNA, RECOMBINANT; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANZYMES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUROFIBROMIN 2; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEX DISTRIBUTION; TRANSCRIPTOME;

EID: 84879100100     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.301169     Document Type: Article

References (46)

1. Keenan NL, Shaw KM; Centers for Disease Control and Prevention (CDC). Coronary heart disease and stroke deaths -United States, 2006. MMWR Surveill Summ. 2011;60:62-66.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128. doi:10.1016/S0140-6736(12)61728-0.
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:-e2-e220. doi:10.1161/CIR.0b013e31823ac046.
4. Heidenreich PA, Trogdon JG, Khavjou OA, et al American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933-944.
5. Zeller T, Blankenberg S, Diemert P. Genomewide association studies in cardiovascular disease-An update 2011. Clin Chem. 2012;58:92-103.
6. Kullo IJ, Ding K. Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med. 2007;4:558-569.
7. Preuss M, König IR, Thompson JR, et al CARDIoGRAM Consortium. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: a Genome-wide association meta-Analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet. 2010;3:475-483.
8. Cupples LA, Arruda HT, Benjamin EJ, et al. The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet. 2007;8:S1.
9. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678. doi:10.1038/nature05911.
10. Ripatti S, Tikkanen E, Orho-Melander M, et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet. 2010;376:1393-1400.
11. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011;43:339-344. doi:10.1038/ng.782.
12. Schunkert H, König IR, Kathiresan S, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333-338.
13. Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD, Kraus WE, Sketch M Jr., Nelson C, Ginsburg GS, Goldschmidt-Clermont PJ, Granger CB. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS One. 2009;4:-e7037.
14. Wingrove JA, Daniels SE, Sehnert AJ, Tingley W, Elashoff MR, Rosenberg S, Buellesfeld L, Grube E, Newby LK, Ginsburg GS, Kraus WE. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet. 2008;1:31-38.
15. Szmit S, Jank M, Maciejewski H, Grabowski M, Glowczynska R, Majewska A, Filipiak KJ, Motyl T, Opolski G. Gene expression profiling in peripheral blood nuclear cells in patients with refractory ischaemic endstage heart failure. J Appl Genet. 2010;51:353-368.
16. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2:-e124. doi:10.1371/journal.pmed.0020124.
17. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50.
18. Joehanes R, Johnson AD, Barb JJ, Raghavachari N, Liu P, Woodhouse KA, O'Donnell CJ, Munson PJ, Levy D. Gene expression analysis of whole blood, peripheral blood mononuclear cells, and lymphoblastoid cell lines from the Framingham Heart Study. Physiol Genomics. 2012;44:59-75.
19. Rosenberg S, Elashoff MR, Beineke P, et al PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med. 2010;153:425-434.
20. Elashoff MR, Wingrove JA, Beineke P, et al. Development of a bloodbased gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 2011;4:26.
21. Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, Dymott JA, Delles C, Dominiczak AF. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci. 2010;119:335-343.
22. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA. 2004;101:6062-6067.
23. Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S, Brosstad F, Damås JK, Russell D, Halvorsen B, Aukrust P. Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis. 2007;195:-e142-e146.
24. Raghavachari N, Xu X, Harris A, Villagra J, Logun C, Barb J, Solomon MA, Suffredini AF, Danner RL, Kato G, Munson PJ, Morris SM Jr., Gladwin MT. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation. 2007;115:1551-1562.
25. Pruitt KD, Tatusova T, Brown GR, Maglott DR. NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res. 2012;40:D130-D135.
26. Kendall RG, Mellors I, Hardy J, Mardle B. Patients with pulmonary and cardiac disease show an elevated proportion of immature reticulocytes. Clin Lab Haematol. 2001;23:27-31.
27. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, Kadoya T, Erdjument-Bromage H, Tempst P, Frappell PB, Bowtell DD, Ronai Z. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell. 2004;117:941-952.
28. Zhang FL, Shen GM, Liu XL, Wang F, Zhao YZ, Zhang JW. Hypoxiainducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions. J Cell Mol Med. 2012;16: 1889-1899.
29. Kondo H, Hojo Y, Tsuru R, Nishimura Y, Shimizu H, Takahashi N, Hirose M, Ikemoto T, Ohya K, Katsuki T, Yashiro T, Shimada K. Elevation of plasma granzyme B levels after acute myocardial infarction. Circ J. 2009;73:503-507.
30. Tsuru R, Kondo H, Hojo Y, Gama M, Mizuno O, Katsuki T, Shimada K, Kikuchi M, Yashiro T. Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome. Heart. 2008;94:305-310.
31. Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens Jr. Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem. 2011;286:41530-41538.
32. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011;10:M111.013284.
33. Danielsen JM, Sylvestersen KB, Bekker-Jensen S, Szklarczyk D, Poulsen JW, Horn H, Jensen LJ, Mailand N, Nielsen ML. Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics. 2011;10:M110.003590.
34. Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, He M, Chen GQ, He JR, Zhao Q. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett. 2011;585:1363-1367.
35. Li B, Cong F, Tan CP, Wang SX, Goff SP. Aph2, a protein with a zf-DHHC motif, interacts with c-Abl and has pro-Apoptotic activity. J Biol Chem. 2002;277:28870-28876.
36. Wyatt E, Wu R, Rabeh W, Park HW, Ghanefar M, Ardehali H. Regulation and cytoprotective role of hexokinase III. PLoS One. 2010;5:-e13823.
37. Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart disease-A novel therapeutic target? FASEB J. 2002;16:135-146.
38. Reeve JL, Duffy AM, O'Brien T, Samali A. Don't lose heart-therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. J Cell Mol Med. 2005;9:609-622.
39. Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease. Apoptosis. 2009;14:536-548.
40. Powell SR, Herrmann J, Lerman A, Patterson C, Wang X. The ubiquitinproteasome system and cardiovascular disease. Prog Mol Biol Transl Sci. 2012;109:295-346.
41. Powell SR. The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol. 2006;291:H1-H19.
42. Bemmo A, Benovoy D, Kwan T, Gaffney DJ, Jensen RV, Majewski J. Gene expression and isoform variation analysis using Affymetrix Exon Arrays. BMC Genomics. 2008;9:529.
43. Laajala E, Aittokallio T, Lahesmaa R, Elo LL. Probe-level estimation improves the detection of differential splicing in Affymetrix exon array studies. Genome Biol. 2009;10:R77.
44. Yang H-C, Liang Y-J, Chen J-W, et al. Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as hypertension susceptibility genes in han Chinese with a Genome-Wide Gene-Based Association Study. Mariño-Ramírez L, ed. PLoS One. 2012;7:-e32907. doi:10.1371/journal.pone.0032907.
45. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325.
46. Huan T, Bin Z, Zhi W, et al. A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol. 2012.